Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 72-77

  Usui, Fumitake ^a   Kimura, Hiroaki ^a   Ohshiro, Taichi ^b   Tatsumi, Kazuki ^a   Kawashima, Akira ^a   Nishiyama, Akiyo ^a   Iwakura, Yo ichiro ^c   Ishibashi, Shun ^b   Takahashi, Masafumi ^a  

^a Center for Molecular Medicine   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atherosclerosis; Cytokines; Diet; Inflammation; Macrophages

Indexed keywords

APOLIPOPROTEIN E; ARGINASE 1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; MSR 1 PROTEIN; OLR1 PROTEIN; SCARB 1 PROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR INFLAMMATION; CELL INFILTRATION; CONTROLLED STUDY; DIET; DISEASE COURSE; LIPID ANALYSIS; LIPID BLOOD LEVEL; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CYTOKINES; DIET; DISEASE MODELS, ANIMAL; INTERLEUKIN-17; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; VASCULITIS;

MUS;

EID: 84859102455     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.117     Document Type: Article

References (24)

1. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
2. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
3. Hata T., Takahashi M., Hida S., Kawaguchi M., Kashima Y., Usui F., Morimoto H., Nishiyama A., Izawa A., Koyama J., Iwakura Y., Taki S., Ikeda U. Critical role of Th17 cells in inflammation and neovascularization after ischaemia. Cardiovasc Res 2011, 90:364-372.
4. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006, 116:1218-1222.
5. Eid R.E., Rao D.A., Zhou J., Lo S.F., Ranjbaran H., Gallo A., Sokol S.I., Pfau S., Pober J.S., Tellides G. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432.
6. Smith E., Prasad K.M., Butcher M., Dobrian A., Kolls J.K., Ley K., Galkina E. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755.
7. Gao Q., Jiang Y., Ma T., Zhu F., Gao F., Zhang P., Guo C., Wang Q., Wang X., Ma C., Zhang Y., Chen W., Zhang L. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 2010, 185:5820-5827.
8. Chen S., Shimada K., Zhang W., Huang G., Crother T.R., Arditi M. IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice. J Immunol 2010, 185:5619-5627.
9. Erbel C., Chen L., Bea F., Wangler S., Celik S., Lasitschka F., Wang Y., Bockler D., Katus H.A., Dengler T.J. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice. J Immunol 2009, 183:8167-8175.
10. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., Esposito B., Perez N., Yasukawa H., Van Snick J., Yoshimura A., Tedgui A., Mallat Z. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009, 206:2067-2077.
11. Madhur M.S., Funt S.A., Li L., Vinh A., Chen W., Lob H.E., Iwakura Y., Blinder Y., Rahman A., Quyyumi A.A., Harrison D.G. Role of interleukin 17 in inflammation atherosclerosis and vascular function in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2011.
12. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
13. Paigen B., Morrow A., Brandon C., Mitchell D., Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985, 57:65-73.
14. Ohshiro T., Matsuda D., Sakai K., Degirolamo C., Yagyu H., Rudel L.L., Omura S., Ishibashi S., Tomoda H. Pyripyropene a, an acyl-coenzyme a:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia. Arterioscler Thromb Vasc Biol 2011, 31:1108-1115.
15. Shiba Y., Takahashi M., Yoshioka T., Yajima N., Morimoto H., Izawa A., Ise H., Hatake K., Motoyoshi K., Ikeda U. M-CSF accelerates neointimal formation in the early phase after vascular injury in mice. The critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol 2007, 27:283-289.
16. Morimoto H., Takahashi M., Izawa A., Ise H., Hongo M., Kolattukudy P.E., Ikeda U. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction. Circ Res 2006, 99:891-899.
17. Leppkes M., Becker C., Ivanov, II, Hirth S., Wirtz S., Neufert C., Pouly S., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Becher B., Littman D.R., Neurath M.F. ROR gamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 2009, 136:257-267.
18. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., Kolls J.K., Flavell R.A. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009, 10:603-609.
19. Ivanov K., Atarashi N., Manel E.L., Brodie T., Shima U., Karaoz D., Wei K.C., Goldfarb C.A., Santee S.V., Lynch T., Tanoue A., Imaoka K., Itoh K., Takeda Y., Umesaki K., Honda D.R. Littman, induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
20. Lichtman A.H., Clinton S.K., Iiyama K., Connelly P.W., Libby P., Cybulsky M.I. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Arterioscler Thromb Vasc Biol 1999, 19:1938-1944.
21. Lee T.S., Yen H.C., Pan C.C., Chau L.Y. The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 1999, 19:734-742.
22. Davenport P., Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125.
23. Moore K.J., Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol 2006, 26:1702-1711.
24. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., Dussiot M., Levillain O., Graff-Dubois S., Nicoletti A., Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5:e8852.